Tech Company Financing Transactions
Alpha Fusion Funding Round
On 10/9/2024, Alpha Fusion raised Series B financing from SBI Investment and private investors.
Transaction Overview
Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
SBI Investment (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its R&D efforts and prepare clinical trials, enhance its supply chain for GMP-grade clinical trial drug production domestically and internationally, and further expand its team.
Company Information
Company Status
Private & Independent
Industry
Transportation
Mailing Address
2-5-13 Umeda, Kita-ku, Osaka-shi
Osaka, Undisclosed
Japan
Osaka, Undisclosed
Japan
Phone
Undisclosed
Website
Email Address
Overview
Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals. Our radiopharmaceuticals utilize Astatine-211 (211At), alpha-emitting particles that are both effective against cancer and safe for patients. This innovation will significantly impact cancer patients who currently have limited treatment options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sunao Fujioka
VP - R & D
Yuichi Tomura
Browse more venture capital transactions:
Prev: 10/9/2024: Q-CTRL venture capital transaction
Next: 10/9/2024: Delta venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs